Min Liao
Direktor/Vorstandsmitglied bei Wuhan Canvest Biotechnology Co., Ltd.
Profil
Min Liao is a Director at Wuhan Canvest Biotechnology Co., Ltd.
since 2019.
Previously, Mr. Liao worked as a Director at YingTong Telecommunication Co., Ltd.
Mr. Liao holds an MBA from City University of Macau.
Aktive Positionen von Min Liao
| Unternehmen | Position | Beginn |
|---|---|---|
Wuhan Canvest Biotechnology Co., Ltd.
 Wuhan Canvest Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Canvest Biotechnology Co., Ltd. engages in the businesses of biological product cell quality testing and biosafety assessment. It provides cell bank construction & preservation, cell verification, production process virus removal & inactivation verification, and corresponding third-party services for biosafety assessment. The company’s technical service items include bacteria & fungus sterility check, mycoplasma examination, internal & exogenous factor inspection, and tumorigenicity test. Wuhan Canvest Biotechnology was founded by Cong Yi Zheng, Geng Fu Xiao, Xiao Bing Xia, Xiang Dong Chen and Xiao Xiong Wu on April 20, 2011 and is headquartered in Wuhan, China. | Direktor/Vorstandsmitglied | 17.09.2019 |
Ehemalige bekannte Positionen von Min Liao
| Unternehmen | Position | Ende |
|---|---|---|
| YINGTONG TELECOMMUNICATION CO.,LTD. | Direktor/Vorstandsmitglied | 09.01.2020 |
Ausbildung von Min Liao
| City University of Macau | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| YINGTONG TELECOMMUNICATION CO.,LTD. | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Wuhan Canvest Biotechnology Co., Ltd.
Wuhan Canvest Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Canvest Biotechnology Co., Ltd. engages in the businesses of biological product cell quality testing and biosafety assessment. It provides cell bank construction & preservation, cell verification, production process virus removal & inactivation verification, and corresponding third-party services for biosafety assessment. The company’s technical service items include bacteria & fungus sterility check, mycoplasma examination, internal & exogenous factor inspection, and tumorigenicity test. Wuhan Canvest Biotechnology was founded by Cong Yi Zheng, Geng Fu Xiao, Xiao Bing Xia, Xiang Dong Chen and Xiao Xiong Wu on April 20, 2011 and is headquartered in Wuhan, China. | Health Technology |
